Corporate Social Responsibility
- SASB ESG Data Tables
- Diversity Policy
- CSR Reports
Corporate Social Responsibility (CSR)
At Genmab, we are committed to building a sustainable and socially responsible biotech. We believe that our actions should benefit our stakeholders and society as a whole. Being socially responsible is fundamental to the way we do business.
Genmab’s commitment to CSR is anchored in our company’s purpose, values and vision. We are dedicated to building a sustainable organization that meets environment, social and governance (ESG) criteria that are relevant to our business operations.
Our CSR Committee, chaired by our CEO, is comprised of representatives from our human resources, investor relations and communications, legal, compliance and research and development functions. The committee ensures CSR activities are carried out effectively and results are communicated clearly and openly.
In 2020, Genmab embarked upon a more focused, business-driven CSR strategy to steer our efforts. Highlights include our commitment to three United Nations Sustainable Development Goals (UN SDGs) and determining the key ESG related activities and disclosures important to our business.
To learn more about our CSR efforts, download 2020 CSR Report.
Starting in 2020, Genmab has identified an initial set of performance indicators that will enable us to better manage and measure our impact going forward. We have adopted the Sustainability Accounting Standards Board (SASB) framework and will follow its guidelines to disclose critical measurements on the environment, society and governance of relevance to our business operations.
In 2021 we will continue to move our CSR efforts forward, look for opportunities to further integrate ESG into our strategic planning and risk management processes, monitor ESG matters of relevance to our business operations and establish clear goals to measure our performance.
For questions about CSR at Genmab, contact us at firstname.lastname@example.org.
SASB ESG Data Tables
The Board of Directors and Executive Management at Genmab are committed to Genmab’s business-driven CSR strategy as well as our efforts to build a sustainable organization that meets environmental, social and governance (ESG) criteria of relevance to our business operations. As the reporting of sustainability metrics continues to evolve over the years, Genmab has and will continue to adapt and improve our metrics and disclosures. Starting in 2020, Genmab has identified an initial set of performance indicators that will enable us to better manage and measure our impact going forward. We have adopted the Sustainability Accounting Standards Board (SASB) framework and will follow its guidelines to disclose critical measurements on the environment, society and governance of relevance to our business operations.More information is coming soon.More information is coming soon.
Policy regarding the Diversity and Proportion of Gender in other Management Levels of the Genmab group:
This policy has been adopted by the Board of Directors of Genmab A/S ("Genmab") in accordance with Section 139a of the Danish Companies Act and the Danish Recommendations on Corporate Governance.
Genmab recognizes the importance of promoting diversity and is committed to continue working towards and maintaining diversity and equal opportunities for employees at all management levels in the Genmab group, regardless of gender, age, race, religion or ethnicity. Genmab encourages talented employees to pursue a career in the company. Genmab regularly conducts employee surveys and employee development interviews to identify barriers – or the perception of barriers – preventing equal opportunities for employees. In connection with recruitment, including recruitment at management level, it is the policy of the Genmab group to meet the company's needs for employees with the right skills and competences, regardless of gender, age, race, religion or ethnicity. When choosing between equally qualified candidates, the diversity among the employees shall be taken into consideration, as it is the aim that both genders attain a representation at management levels of at least 40%. In connection with recruitment for managerial positions it must be ensured that the employment procedures are designed to give men and women equal opportunities to apply for and obtain managerial positions and, where possible, that the candidates invited for interview include both men and women. The company's focus on diversity among its employees, including at management levels, must be visible during recruitment.
The policy may be amended by the Board of Directors and should be interpreted in accordance with applicable equal rights and anti-discrimination legislation in Denmark, in force from time to time.
A Target Figure for the Number of Women in the Board of Directors of Genmab A/S has been established. Click here for more information.
More information is coming soon.